A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel
- 30 June 1992
- journal article
- Published by Elsevier in Contraception
- Vol. 45 (6) , 523-532
- https://doi.org/10.1016/0010-7824(92)90103-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1991
- IntroductionAmerican Journal of Obstetrics and Gynecology, 1990
- Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosteroneContraception, 1990
- Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and DesogestrelActa Obstetricia et Gynecologica Scandinavica, 1988
- A new low-dose estrogen oral contraceptive combination: Effect on endocrine parameters and lipid statusContraception, 1987
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- A New Look at ProgestogensClinics in Obstetrics and Gynaecology, 1984
- Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrelFertility and Sterility, 1984
- Measurement of Ceruloplasmin from Its Oxidase Activity in Serum by Use of o-Dianisidine DihydrochlorideClinical Chemistry, 1974
- A Simplified Method for the Quantitative Determination of Testosterone-Estradiol-Binding Globulin Activity in Human PlasmaJournal of Clinical Endocrinology & Metabolism, 1972